Shares of Merck KGaA (FRA:MRK) have received a consensus rating of “Hold” from the twenty-two research firms that are presently covering the firm, Marketbeat.com reports. Sixteen equities research analysts have rated the stock with a hold recommendation and six have given a buy recommendation to the company. The average 12-month price objective among brokers that have updated their coverage on the stock in the last year is €108.90 ($128.12).

MRK has been the subject of a number of research reports. Nord/LB reiterated a “neutral” rating on shares of Merck KGaA in a report on Wednesday, June 28th. Credit Suisse Group set a €106.00 ($124.71) price objective on shares of Merck KGaA and gave the company a “neutral” rating in a report on Wednesday, July 26th. Goldman Sachs Group, Inc. (The) set a €105.00 ($123.53) price objective on shares of Merck KGaA and gave the company a “neutral” rating in a report on Thursday, August 17th. DZ Bank AG reiterated a “neutral” rating on shares of Merck KGaA in a report on Monday, May 29th. Finally, Kepler Capital Markets set a €119.00 ($140.00) price objective on shares of Merck KGaA and gave the company a “buy” rating in a report on Monday, July 31st.

COPYRIGHT VIOLATION WARNING: This article was originally published by TheOlympiaReport and is the sole property of of TheOlympiaReport. If you are accessing this article on another site, it was illegally stolen and republished in violation of US & international trademark & copyright legislation. The original version of this article can be viewed at https://theolympiareport.com/2017/08/27/analysts-set-merck-kgaa-mrk-price-target-at-108-90.html.

Merck KGaA (FRA MRK) traded up 0.867% on Tuesday, hitting €92.973. 425 shares of the stock traded hands. The stock has a market cap of €40.42 billion and a P/E ratio of 24.237. Merck KGaA has a 12-month low of €89.00 and a 12-month high of €115.00. The stock has a 50-day moving average price of €95.91 and a 200 day moving average price of €103.18.

Merck KGaA Company Profile

.

Analyst Recommendations for Merck KGaA (FRA:MRK)

Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with Analyst Ratings Network's FREE daily email newsletter.